| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |